AHA provides recommendations to Consumer Product Safety Commission on modernized product injury surveillance system

Aug 12, 2026 - 04:18 PM
CMS-medicare-AHA-comment

The AHA today provided comments to the Consumer Product Safety Commission on its agenda and priorities for fiscal years 2027 and 2028, specifically focusing on recommendations for National Electronic Injury Surveillance System modernization efforts. As announced last month and outlined in their proposed strategy, the CPSC will replace its manual coding process with an electronic data exchange through a Qualified Information Network. In the comment letter, the AHA urged the CPSC to limit data requests to only data necessary for NEISS’ injury tracking and surveillance purposes and to provide additional guidance on how the CPSC will ensure compliance with data security and privacy laws. The AHA also recommended the commission minimize added financial costs and administrative burden to the healthcare system by keeping hospital participation voluntary. In addition, the AHA recommended the CPSC pursue a notice-and-comment period for the updated NEISS system.

Related News Articles

Headline
Highest FDA recall issued for certain convenience kits
The Food and Drug Administration Aug. 3 identified Class I recalls of two convenience kit products. Certain kits by Medline…
Headline
FDA identifies, issues Class 1 recalls
The Food and Drug Administration has identified a recall by Cook Medical of Zenith Alpha 2 Thoracic Endovascular Graft proximal components after Cook Medical…
Headline
FDA issues early alerts for certain Baxter, Abiomed products
The Food and Drug Administration has issued early alerts for certain Spectrum infusion pumps from Baxter and Abiomed Automated Impella Controllers. The agency…
Headline
White House announces tariffs on goods imported from Canada, Mexico, China
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed…
Headline
FDA evaluating certain plastic syringes made in China
The Food and Drug Administration is evaluating Chinese-made plastic syringes used to inject or withdraw fluids from the body, citing concern that they may…
Headline
FDA announces Class I ventilator recall for Draeger product’s pediatric use
Draeger Medical, Inc. is recalling its Carina Ventilators due to the presence of contaminants in the device’s airpath, which exceed acceptable levels if…